Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis
NCT01648933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2018-10-11
Summary
The study aims at assessing diagnostic and therapeutic impact of Rubidium-82 PET in cardiac sarcoidosis.
Conditions
- Sarcoidosis
Interventions
- RADIATION
-
Rubidium PET
Myocardial Perfusion Imaging
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Dominique Le Guludec, MD, PhD · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2015-09-30
- Completion
- 2017-02-28
Countries
- France
Study Locations
More Related Trials
-
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
NCT04968886 ·Status: UNKNOWN
-
Serological Test for the Diagnosis of TB
NCT02898623 ·Status: TERMINATED
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome
NCT05354583 ·Status: COMPLETED
-
A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides
NCT05899400 ·Status: COMPLETED
-
Same Day Diagnosis of Extrapulmonary TB (TB Serositis and TB Meningitis).
NCT06135818 ·Status: RECRUITING ·Phase: NA
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up of Autoantibodies in Active Tuberculosis
NCT00551226 ·Status: UNKNOWN
-
AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation
NCT05889364 ·Status: UNKNOWN
-
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
NCT05220163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
NCT03220464 ·Status: UNKNOWN ·Phase: NA
-
Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis
NCT02776150 ·Status: UNKNOWN
-
Validation of Artificial Intelligence Enabled TB Screening and Diagnosis in Zambia
NCT05139940 ·Status: COMPLETED
-
Using Biomarkers to Predict TB Treatment Duration
NCT02821832 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF
NCT01371916 ·Status: COMPLETED
-
Accuracy and Feasibility of Xpert Ultra
NCT03072576 ·Status: COMPLETED
-
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis
NCT01252992 ·Status: COMPLETED
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Diagnosing of Acute Tuberculosis
NCT03667742 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
NCT01136161 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Antituberculous Therapy in Management of Sarcoidosis
NCT01245036 ·Status: COMPLETED ·Phase: NA
-
Sensitivity and Specificity of Xpert MTB/RIF Ultra
NCT06058065 ·Status: NOT_YET_RECRUITING
-
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
NCT06485895 ·Status: RECRUITING ·Phase: NA
-
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
NCT05537038 ·Status: COMPLETED ·Phase: PHASE1